Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Please find enclosed prior ....
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec Lifesciences has informed the stock exchanges that its Board of Directors will meet on Friday, 30 January 2026. The key agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results for the third quarter (Q3FY26) and the nine-month period ended 31 December 2025. The results will first be reviewed by the Audit Committee before being placed before the Board. The filing is a standard regulatory disclosure under SEBI Listing Regulations.
This is a routine pre-results intimation with no material information disclosed yet. Investors should watch for the actual Q3 numbers on 30 January 2026, which could move the stock depending on revenue and profit performance versus expectations.